SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-005974
Filing Date
2022-04-26
Accepted
2022-04-26 16:05:58
Documents
5
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220609xdef14a.htm DEF 14A 778359
2 GRAPHIC tmb-20220609xdef14a017.jpg GRAPHIC 163654
3 GRAPHIC tmb-20220609xdef14a018.jpg GRAPHIC 135493
4 GRAPHIC tmb-20220609xdef14a003.jpg GRAPHIC 9237
5 GRAPHIC tmb-20220609xdef14a004.jpg GRAPHIC 1490
  Complete submission text file 0001558370-22-005974.txt   1206664
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40925 | Film No.: 22854327
SIC: 2834 Pharmaceutical Preparations